Speech-Language Pathologists in Flora, IL Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Shaimaa Raheem Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 232 Given Dr, Flora, IL 62839 Phone: 618-662-8381

Katie Brianna Vanblaricum Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 Shadwell Ave, Flora, IL 62839 Phone: 618-662-8361

Brittney Howell, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 232 Given Dr, Flora, IL 62839 Phone: 618-662-4384    Fax: 618-662-4384

Mr. Ryan Kent Spicer, B.S.M.S. CCC/SLP-L Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 445 Emory St, Flora, IL 62839 Phone: 618-662-2014

Kimberly Scarbrough Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 445 Emory St, Flora, IL 62839 Phone: 618-662-2014    Fax: 618-662-2014

News Archive

C-sections on the rise: One in three mothers opting for procedure

According to the latest study reports, one in three births in the U.S. are now delivered by Caesarean section, which is an all time high and an increasd of 25 percent over seven years.

Researchers launch clinical trials to test novel cellular-immunotherapy to treat three types of blood cancer

Cancer immunology is based upon boosting the body's own immune system to vanquish malignancies. It is among the fastest growing areas of oncology research. Researchers at UC San Diego Moores Cancer Center have launched three clinical trials to test the safety and efficacy of a novel cellular-immunotherapy that uses modified T cells - one of the immune system's primary weapons - to treat three different types of blood cancer that often defy existing therapies.

Common gene variation lessens Tamoxifen's benefit

Researchers have discovered that one of the most commonly prescribed drugs for breast cancer, tamoxifen, may not be as effective for women who inherit a common genetic variation.

Life-sustaining interventions: Hospitals 'moving toward the middle'

Patients admitted to hospitals with higher-intensity end-of-life care live longer than those admitted to hospitals with low-intensity approaches, according to a University of Pittsburgh study available online and published in the February issue of the journal Medical Care. Higher-intensity care refers to greater use of life-sustaining measures such as ICU admission, intubation or mechanical ventilation, kidney dialysis and feeding tubes.

Research findings help explain diverse genetic susceptibility for alcohol use disorders

A genetic variant of a receptor in the brain's reward circuitry plays an important role in determining whether the neurotransmitter dopamine is released in the brain following alcohol intake, according to a study led by researchers at the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health. Dopamine is involved in transmitting the euphoria and other positive subjective effects produced by alcohol.

Read more Medical News

› Verified 2 days ago